Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes

Journal of Virology

Volumn 85, Issue 15, 2011, Pages 7523-7534

  Herbeck, Joshua T ^a   Rolland, Morgane ^a   Liu, Yi ^a   McLaughlin, Sherry ^a   McNevin, John ^b   Zhao, Hong ^a   Wong, Kim ^a   Stoddard, Julia N ^a   Raugi, Dana ^a   Sorensen, Stephanie ^a   Genowati, Indira ^a   Birditt, Brian ^a   McKay, Angela ^a   Diem, Kurt ^a   Maust, Brandon S ^a   Deng, Wenjie ^a   Collier, Ann C ^a   Stekler, Joanne D ^a   McElrath, M Juliana ^b   Mullins, James I ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; VIRUS ENVELOPE PROTEIN;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MALE HOMOSEXUAL; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; BASE SEQUENCE; DEMOGRAPHY; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOLUTION, MOLECULAR; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; STOCHASTIC PROCESSES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79960419997     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02697-10     Document Type: Article

References (77)

1. Abrahams, M. R., et al. 2009. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 83:3556-3567.
2. Allen, T. M., et al. 2005. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 79:13239-13249.
3. Anderson, J. A., et al. 2010. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 6:e1001053.
4. Bar, K. J., et al. 2010. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J. Virol. 84:6241-6247.
5. Bhattacharya, T., et al. 2007. Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science 315:1583-1586.
6. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
7. Brockman, M. A., et al. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J. Virol. 84:11937-11949.
8. Bunce, M., G. C. Fanning, and K. I. Welsh. 1995. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP). Tissue Antigens 45:81-90.
9. Busch, M. P., and G. A. Satten. 1997. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 102:117-126.
10. Buus, S., et al. 2003. Sensitive quantitative predictions of peptide-MHC binding by a "Query by Committee" artificial neural network approach. Tissue Antigens 62:378-384.
11. Byrn, R. A., D. Zhang, R. Eyre, K. McGowan, and A. A. Kiessling. 1997. HIV-1 in semen: an isolated virus reservoir. Lancet 350:1141.
12. Delwart, E., et al. 2002. Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 16:189-195.
13. Delwart, E. L., et al. 1998. Human immunodeficiency virus type 1 populations in blood and semen. J. Virol. 72:617-623.
14. Delwart, E. L., H. W. Sheppard, B. D. Walker, J. Goudsmit, and J. I. Mullins. 1994. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68:6672-6683.
15. Diem, K., et al. 2008. Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV). AIDS Res. Hum. Retroviruses 24: 561-571.
16. Duda, A., et al. 2009. HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J. Virol. 83:1228-1239.
17. Fiebig, E. W., et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
18. Fu, Y. X., and W. H. Li. 1993. Statistical tests of neutrality of mutations. Genetics 133:693-709.
19. Furuta, Y., T. Bergstrom, G. Norkrans, and P. Horal. 1994. HIV type 1 V3 sequence diversity in contact-traced Swedish couples at the time of sexual transmission. AIDS Res. Hum. Retroviruses 10:1187-1191.
20. Gojobori, T., Y. Yamaguchi, K. Ikeo, and M. Mizokami. 1994. Evolution of pathogenic viruses with special reference to the rates of synonymous and nonsynonymous substitutions. Jpn. J. Genet. 69:481-488.
21. Goonetilleke, N., et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
22. Gottlieb, G. S., et al. 2008. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J. Infect. Dis. 197:1011-1015.
23. Guindon, S., and O. Gascuel. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52:696-704.
24. Haaland, R. E., et al. 2009. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5:e1000274.
25. Heckerman, D., C. Kadie, and J. Listgarten. 2006. Leveraging information across HLA alleles/supertypes improves epitope prediction, p. 296-308. In Proceedings of the Tenth Annual International Conference on Research in Computational Molecular Biology (RECOMB), Venice, Italy.
26. Herbeck, J. T., et al. 2006. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J. Virol. 80:1637-1644.
27. Hollingsworth, T. D., R. M. Anderson, and C. Fraser. 2008. HIV-1 transmission, by stage of infection. J. Infect. Dis. 198:687-693.
28. Hudson, R. R., M. Kreitman, and M. Aguade. 1987. A test of neutral molecular evolution based on nucleotide data. Genetics 116:153-159.
29. Hughes, G. J., et al. 2009. Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom. PLoS Pathog. 5:e1000590.
30. Jensen, M. A., et al. 2003. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 Env V3 loop sequences. J. Virol. 77:13376-13388.
31. Jordan, M. R., et al. 2010. Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations. J. Virol. Methods 168:114-120.
32. Kawashima, Y., et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-645.
33. Kearney, M., et al. 2009. Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J. Virol. 83:2715-2727.
34. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
35. Koup, R. A., et al. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
36. Lassen, K. G., et al. 2009. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog. 5:e1000377.
37. Learn, G. H., et al. 2002. Virus population homogenization following acute human immunodeficiency virus type 1 infection. J. Virol. 76:11953-11959.
38. Lee, H. Y., et al. 2009. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261:341-360.
39. Li, B., et al. 2007. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. J. Virol. 81:193-201.
40. Li, H., et al. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890.
41. Liu, Y., et al. 2006. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J. Virol. 80:9519-9529.
42. Liu, Y., et al. 2007. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape. J. Virol. 81:12179-12188.
43. Lyles, R. H., et al. 2000. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J. Infect. Dis. 181: 872-880.
44. Maddison, W. P., and D. R. Maddison. 2001. MacClade: analysis of phylogeny and character evolution, version 4. Sinauer Associates, Inc., Sunderland, MA.
45. Matthews, P. C., et al. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 82:8548-8559.
46. Mellors, J. W., et al. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
47. Mellors, J. W., et al. 2007. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 297:2349-2350.
48. Mellors, J. W., et al. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170. (Erratum, 275:14, 1997.)
49. Nielsen, M., et al. 2003. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12:1007-1017.
50. Nowak, M. A., et al. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606-611.
51. Pilcher, C. D., et al. 2004. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189:1785-1792.
52. Pillai, S. K., et al. 2005. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J. Virol. 79:1734-1742.
53. Pond, S. L., S. D. Frost, and S. V. Muse. 2005. HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676-679.
54. Poss, M., et al. 1998. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J. Virol. 72:8240-8251.
55. Ritola, K., et al. 2004. Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J. Virol. 78:11208-11218.
56. Rodrigo, A. G., and J. I. Mullins. 1996. Human immunodeficiency virus type 1 molecular evolution and the measure of selection. AIDS Res. Hum. Retroviruses 12:1681-1685.
57. Rolland, M., D. C. Nickle, and J. I. Mullins. 2007. HIV-1 groupMconserved elements vaccine. PLoS Pathog. 3:e157.
58. Rolland, M., et al. 2011. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat. Med. 17:366-371.
59. Rousseau, C., et al. 2006. Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J. Virol. Methods 136:118-125.
60. Rozas, J., and R. Rozas. 1999. DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175.
61. Salazar-Gonzalez, J. F., et al. 2008. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82:3952-3970.
62. Salazar-Gonzalez, J. F., et al. 2009. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206:1273-1289.
63. Scarlatti, G., et al. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259-1265.
64. Schacker, T. W., J. P. Hughes, T. Shea, R. W. Coombs, and L. Corey. 1998. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 128:613-620.
65. Shankarappa, R., et al. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
66. Sheppard, H. W., and M. S. Ascher. 1992. The relationship between AIDS and immunologic tolerance. J. Acquir. Immune Defic. Syndr. 5:143-147.
67. Shriner, D., A. G. Rodrigo, D. C. Nickle, and J. I. Mullins. 2004. Pervasive genomic recombination of HIV-1 in vivo. Genetics 167:1573-1583.
68. Slatkin, M., and R. R. Hudson. 1991. Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populations. Genetics 129:555-562.
69. Tajima, F. 1989. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595.
70. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
71. Troyer, R. M., et al. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 5:e1000365.
72. Wawer, M. J., et al. 2005. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191:1403-1409.
73. Wolfs, T. F., G. Zwart, M. Bakker, and J. Goudsmit. 1992. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189:103-110.
74. Wood, N., et al. 2009. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog. 5:e1000414.
75. Zhang, L. Q., et al. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
76. Zhang, M., et al. 2004. Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14:1229-1246.
77. Zhu, T., et al. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.